ArticleOncotarget2016

Targeting FOSB with a cationic antimicrobial peptide, TP4, for treatment of triple-negative breast cancer.

Chen-Hung Ting et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.